Literature DB >> 19180924

[Expression of prostate stem cell antigen and Claudin-4 in human pancreatic carcinoma].

Wen-Bin Yagn1, Feng Cai, Chuan-Tao Cheng, Gang Cao, Zhao-Yin Qin.   

Abstract

OBJECTIVE: To investigate the expressions of prostate stem cell antigen (PSCA) and Claudin-4 in human pancreatic carcinoma and to discuss its role in the ontogenesis of pancreatic cancer.
METHODS: Pancreatic carcinoma tissue microarray was constructed, containing 100 cores of 10 normal adult pancreas tissues, 12 chronic pancreatitis tissues, and 78 pancreatic carcinomas. The expressions of PSCA and Claudin-4 were detected using immunohistochemical method and the relationship between PSCA and Claudin-4 and the pancreatic carcinoma was analyzed.
RESULTS: The positive expression rates of PSCA and Claudin-4 protein in pancreatic carcinoma were 79. % and 88. % respectively. PSCA and Claudin-4 staining were more intense in malignant cells than in chronic pancreatic tissues and normal adult pancreas tissues. No evidence was found for an association between expressions of PSCA and Claudin-4 and other variables, including gender, age at surgery, and tumor grade.
CONCLUSIONS: The expressions of PSCA and Claudin-4 are related to the pancreatic carcinomas. PSCA and Claudin-4 play a role in the development of pancreatic cancer, but PSCA and Claudin-4 are not correlated with the clinical pathology of tumor.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19180924

Source DB:  PubMed          Journal:  Zhongguo Yi Xue Ke Xue Yuan Xue Bao        ISSN: 1000-503X


  2 in total

1.  Association between genetic subgroups of pancreatic ductal adenocarcinoma defined by high density 500 K SNP-arrays and tumor histopathology.

Authors:  María Laura Gutiérrez; Luís Muñoz-Bellvis; María del Mar Abad; Oscar Bengoechea; María González-González; Alberto Orfao; José María Sayagués
Journal:  PLoS One       Date:  2011-07-21       Impact factor: 3.240

2.  Association between PSCA mRNA expression levels and rs2294008 polymorphism in transitional cell cancer of the bladder.

Authors:  Kewen Zheng; Zhigang Chen; Ye Tian; Gangyue Hao
Journal:  Oncol Lett       Date:  2014-11-24       Impact factor: 2.967

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.